2 completed, 2 not yet recruiting, 1 active not recruiting, 1 withdrawn. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Not yet recruiting 2, Active not recruiting 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Vestibular Migraine: new trials by email Literature Review of Vestibular Migraine trials Research Report on Vestibular Migraine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study Rimegepant, Flunarizine - Vestibular Migraine | Phase 2 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 400 | 2026-12-01 | 2026-08-07 |
| The R-E-V-I-V-A-L Study Rimegepant, Placebo - Vestibular Migraine | Phase 2 | Active not recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 240 | 2025-06-01 | 2025-06-25 |
| A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment Rimegepant, Placebo - Vestibular Migraine, Adults 18 Years and Older (no Other Exclusion Criteria) | Phase 2 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 240 | 2025-06-01 | 2025-05-14 |
| Galcanezumab for Vestibular Migraine Galcanezumab Prefilled Syringe, Placebo - Vestibular Migraine | Phase 2 | Completed | University of California, San Francisco | 40 | 2020-09-18 | 2024-12-10 |
| 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine 4-aminopyridine, Atenolol, Placebo - Vestibular Migraine, Migraine Disorders | Phase 2 | Withdrawn | Massachusetts Eye and Ear Infirmary | 2019-01-01 | 2024-07-01 | |
| Rizatriptan for Episodic Dizziness in Vestibular Migraine Rizatriptan, Placebo - Vestibular Migraine, Migrainous Vertigo | Phase 2 / Phase 3 | Completed | Robert W. Baloh | 223 | 2014-12-01 | 2021-11-04 |
Migraine Disorders (1) · Vestibular Diseases (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Ear Diseases (1) · Headache Disorders (1) · Headache Disorders, Primary (1) · Labyrinth Diseases (1) · Nervous System Diseases (1) · Otorhinolaryngologic Diseases (1)
rimegepant sulfate (3) · 4-Aminopyridine (1) · Atenolol (1) · Flunarizine (1) · Sugars (1) · erenumab (1) · rizatriptan (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (3) · Massachusetts Eye and Ear Infirmary (1) · Robert W. Baloh (1) · University of California, San Francisco (1)
United States (3) · China (2)
Jeffrey D Sharon, MD (1) · Robert W Baloh, M.D. (1)
PMID 39344988, PMID 11222783, PMID 26224714, PMID 30020261, PMID 31311674, PMID 36946234, PMID 37042545, PMID 37073858, PMID 37210098, PMID 40354049, PMID 41430107